On 04 nov 2025, ZTS reported earnings of 1.70 USD per share (EPS) for Q3 25, beating the estimate of 1.63 USD, resulting in a 3.79% surprise. Revenue reached 2.40 mil millones, compared to an expected 2.43 mil millones, with a -1.43% difference. The market reacted with a -13.78% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of 1.41 USD, with revenue projected to reach 2.38 mil millones USD, implying an reducir of -17.06% EPS, and reducir of -0.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26 dic 2025 para Q4 25
Estimar
-$0.49
Actual
-
Sorpresa
-
Preguntas frecuentes
What were ZOETIS INC.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ZOETIS INC. reported EPS of $1.70, beating estimates by 3.79%, and revenue of $2.40B, -1.43% below expectations.
How did the market react to ZOETIS INC.'s Q3 2025 earnings?
The stock price moved down -13.78%, changed from $144.35 before the earnings release to $124.46 the day after.
When is ZOETIS INC. expected to report next?
The next earning report is scheduled for 12 feb 2026.
What are the forecasts for ZOETIS INC.'s next earnings report?
Based on 17
analistas, ZOETIS INC. is expected to report EPS of $1.41 and revenue of $2.38B for Q4 2025.